A-share subscription | Jiyuan Group (603262.SH) opens subscription Professional in research and development innovation and industrialization of dietary nutrition supplements.

On July 14th, Tiyuan Group (603262.SH) started its subscription with an issue price of 10.88 yuan per share, with a subscription limit of 12,000 shares, a P/E ratio of 25.51 times, an industry P/E ratio of 27.69, and it belongs to the main board of the Shanghai Stock Exchange, with Orient as the sponsor. The prospectus shows that Tiyuan Group is an international enterprise group specializing in the research and development innovation and industrialization of dietary nutrition supplement products. The company adheres to scientific research and clinical trials as the basis, continuously providing original and customized nutritional ingredients and formulation products for the global dietary nutrition supplement industry. Tiyuan Group is a major pioneer and market promoter of the global HMB nutrient, leading and promoting the market access of HMB nutrients in multiple countries and regions. The company's myHMB brand raw materials have multiple core patents and rich clinical data accumulation globally, and have been selected into the list of internationally renowned brands cultivated and developed by Wuxi City. With the key technology of fine processing and customized treatment of self-developed glucosamine raw materials, the company provides high reliability and high production efficiency customized raw material product solutions for global brand customers. The company's GlucosaGreen brand raw materials have gradually become a globally renowned and highly recognized glucosamine brand. In recent years, with advanced R&D system, patent advantages, high industry status, and brand recognition, Tiyuan Group has successively established cooperation and achieved bulk supply with many global well-known companies such as Formulife (dietary nutrition), Sanofi (dietary nutrition), Royal Canin (animal nutrition), Lintbells (pet health), Nestle (food and beverage), Johnson & Johnson (dietary nutrition), DuPont Nutrition & Biosciences (dietary nutrition), and Mengniu (dairy products), expanding the application fields and market space of the company's core raw materials and formulation products, laying the product foundation and customer base for the continuous growth of future performance. In terms of finance, in 2022, 2023, and 2024, Tiyuan Group achieved operating revenues of approximately 947 million yuan, 892 million yuan, and 1.002 billion yuan respectively; and net profits of approximately 144 million yuan, 161 million yuan, and 175 million yuan respectively during the same period.